ResVax RSV Vaccine — Vax-Before-Travel

ResVax RSV Vaccine

Fact checked by Robert Carlson, MD

Aug 15

3 min read

ResVax Demonstrated Significant Vaccine Efficacy Against Infant Pneumonia Early in Life

Novavax ResVax is an aluminum adjuvanted respiratory syncytial virus fusion protein recombinant nanoparticle vaccine

happy little girl with dad

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Jun 10

4 min read

ResVax Vaccine Continues to the RSV Finish Line

Novavax ResVax vaccine candidate is an RSV fusion protein recombinant nanoparticle vaccine with aluminum phosphate as an adjuvant

new born baby feet in a basket

Respiratory Syncytial Virus (RSV)

Fact checked by Kelley Lu, PharmD

Mar 27

5 min read

Insights for Developing RSV Vaccines

Synagis needs to provide both the antiviral activity and a countermeasure to the viral distortion of the host immune response

Respiratory Syncytial Virus (RSV)

Fact checked by Robert Carlson, MD

Dec 28

4 min read

Wall Street Is Betting on a Future RSV Vaccine Approval

NovaVax ResVax respiratory syncytial virus vaccine candidate is in phase 3 clinical study named PREPARE

wall street sign

Respiratory Syncytial Virus (RSV)